by University of Bristol With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections. Candida albicans, a well-known yeast usually seen in the mouth, skin, gut and vagina, is reported to form biofilms...
By Nick Lavars Scientists are reporting some promising findings from a large prostate cancer trial, where patients were administered a drug typically used to treat breast cancer. The drug proved more effective than standard hormone treatments at applying the brakes to the disease, with the scientists hopeful it can lead to approval this year of...
by University of California – San Diego UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have therapeutic value for COVID-19 patients who have developed or at high risk of developing serious...
by University of Science and Technology of China Rapidly increasing cancer incidence and mortality worldwide have raised great challenges for the currently available anticancer options, which warrants the development of new therapeutic modalities based on novel antitumor mechanisms. Ferroptosis, a recently discovered form of non-apoptotic cell death, is one such candidate and has already demonstrated...
PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a “magic bullet” to prevent and cure CoVid-19. And the medicines can – if used rashly – have serious side effects. Although there have been some encouraging signs from small-scale preliminary trials of the drugs chloroquine (CQ)...
Technology Org Science and technology news Drug reduces the risk of child sexual abuse Posted Today A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published in the journal JAMA Psychiatry shows. About one in...
Now, his team has figured out how mutations in this protein, called synaptotagmin-1 or syt1, can lead to a rare condition known as syt1-associated neurodevelopmental disorder. The scientists’ discovery led them to identify a possible treatment, Chapman and his colleagues report May 1, 2020, in the journal Neuron. An email prompted the team’s investigation. In...
A widely used rapid COVID-19 test can produce false negatives if a certain solution is used to move or store patients’ samples, the test’s maker said. Last week, Abbott Laboratories told health care providers not to use solutions known as “viral transport media” for samples tested on its ID NOW device, CNN reported. Swabs with...
BY: MAHESH NARAYAN. EL PASO, Texas – Researchers in The University of Texas at El Paso’s Department of Chemistry and Biochemistry have developed a nanohybrid vehicle that can be used to optimally deliver drugs into the human body. The research was published in April 2020 in ACS Applied Materials & Interfaces. Leading the study are...
by University of Birmingham A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium. The research paves the way for development of new antibiotic drugs targeted at emerging strains of TB. Tuberculosis (TB) remains a global health challenge, responsible for...
